Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer's disease. 2021

Min Su Kang, and Arturo Aliaga Aliaga, and Monica Shin, and Sulantha Mathotaarachchi, and Andrea L Benedet, and Tharick A Pascoal, and Joseph Therriault, and Mira Chamoun, and Melissa Savard, and Gabriel A Devenyi, and Axel Mathieu, and M Mallar Chakravarty, and Åsa Sandelius, and Kaj Blennow, and Henrik Zetterberg, and Jean-Paul Soucy, and A Claudio Cuello, and Gassan Massarweh, and Serge Gauthier, and Pedro Rosa-Neto, and
Translational Neuroimaging Laboratory, McGill University Research Centre for Studying in Aging, Montreal, QC, Canada.

Neurofilament light chain (NFL) measurement has been gaining strong support as a clinically useful neuronal injury biomarker for various neurodegenerative conditions. However, in Alzheimer's disease (AD), its reflection on regional neuronal injury in the context of amyloid pathology remains unclear. This study included 83 cognitively normal (CN), 160 mild cognitive impairment (MCI), and 73 AD subjects who were further classified based on amyloid-beta (Aβ) status as positive or negative (Aβ+ vs Aβ-). In addition, 13 rats (5 wild type and 8 McGill-R-Thy1-APP transgenic (Tg)) were examined. In the clinical study, reduced precuneus/posterior cingulate cortex and hippocampal grey matter density were significantly associated with increased NFL concentrations in cerebrospinal fluid (CSF) or plasma in MCI Aβ+ and AD Aβ+. Moreover, AD Aβ+ showed a significant association between the reduced grey matter density in the AD-vulnerable regions and increased NFL concentrations in CSF or plasma. Congruently, Tg rats recapitulated and validated the association between CSF NFL and grey matter density in the parietotemporal cortex, entorhinal cortex, and hippocampus in the presence of amyloid pathology. In conclusion, reduced grey matter density and elevated NFL concentrations in CSF and plasma are associated in AD-vulnerable regions in the presence of amyloid positivity in the AD clinical spectrum and amyloid Tg rat model. These findings further support the NFL as a neuronal injury biomarker in the research framework of AD biomarker classification and for the evaluation of therapeutic efficacy in clinical trials.

UI MeSH Term Description Entries
D007382 Intermediate Filaments Cytoplasmic filaments intermediate in diameter (about 10 nanometers) between the microfilaments and the microtubules. They may be composed of any of a number of different proteins and form a ring around the cell nucleus. Tonofilaments,Neurofilaments,Filament, Intermediate,Filaments, Intermediate,Intermediate Filament,Neurofilament,Tonofilament
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001284 Atrophy Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes. Atrophies
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid
D016875 tau Proteins Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES). tau Protein,Protein, tau,Proteins, tau
D016900 Neurofilament Proteins Type III intermediate filament proteins that assemble into neurofilaments, the major cytoskeletal element in nerve axons and dendrites. They consist of three distinct polypeptides, the neurofilament triplet. Types I, II, and IV intermediate filament proteins form other cytoskeletal elements such as keratins and lamins. It appears that the metabolism of neurofilaments is disturbed in Alzheimer's disease, as indicated by the presence of neurofilament epitopes in the neurofibrillary tangles, as well as by the severe reduction of the expression of the gene for the light neurofilament subunit of the neurofilament triplet in brains of Alzheimer's patients. (Can J Neurol Sci 1990 Aug;17(3):302) Neurofilament Protein,Heavy Neurofilament Protein,Neurofilament Triplet Proteins,Neurofilament Protein, Heavy,Protein, Heavy Neurofilament,Protein, Neurofilament,Proteins, Neurofilament,Proteins, Neurofilament Triplet,Triplet Proteins, Neurofilament
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D060825 Cognitive Dysfunction Diminished or impaired mental and/or intellectual function. Cognitive Disorder,Mild Cognitive Impairment,Cognitive Decline,Cognitive Impairments,Mental Deterioration,Cognitive Declines,Cognitive Disorders,Cognitive Dysfunctions,Cognitive Impairment,Cognitive Impairment, Mild,Cognitive Impairments, Mild,Decline, Cognitive,Declines, Cognitive,Deterioration, Mental,Deteriorations, Mental,Disorder, Cognitive,Disorders, Cognitive,Dysfunction, Cognitive,Dysfunctions, Cognitive,Impairment, Cognitive,Impairment, Mild Cognitive,Impairments, Cognitive,Impairments, Mild Cognitive,Mental Deteriorations,Mild Cognitive Impairments

Related Publications

Min Su Kang, and Arturo Aliaga Aliaga, and Monica Shin, and Sulantha Mathotaarachchi, and Andrea L Benedet, and Tharick A Pascoal, and Joseph Therriault, and Mira Chamoun, and Melissa Savard, and Gabriel A Devenyi, and Axel Mathieu, and M Mallar Chakravarty, and Åsa Sandelius, and Kaj Blennow, and Henrik Zetterberg, and Jean-Paul Soucy, and A Claudio Cuello, and Gassan Massarweh, and Serge Gauthier, and Pedro Rosa-Neto, and
September 2022, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia,
Min Su Kang, and Arturo Aliaga Aliaga, and Monica Shin, and Sulantha Mathotaarachchi, and Andrea L Benedet, and Tharick A Pascoal, and Joseph Therriault, and Mira Chamoun, and Melissa Savard, and Gabriel A Devenyi, and Axel Mathieu, and M Mallar Chakravarty, and Åsa Sandelius, and Kaj Blennow, and Henrik Zetterberg, and Jean-Paul Soucy, and A Claudio Cuello, and Gassan Massarweh, and Serge Gauthier, and Pedro Rosa-Neto, and
February 2021, Molecular psychiatry,
Min Su Kang, and Arturo Aliaga Aliaga, and Monica Shin, and Sulantha Mathotaarachchi, and Andrea L Benedet, and Tharick A Pascoal, and Joseph Therriault, and Mira Chamoun, and Melissa Savard, and Gabriel A Devenyi, and Axel Mathieu, and M Mallar Chakravarty, and Åsa Sandelius, and Kaj Blennow, and Henrik Zetterberg, and Jean-Paul Soucy, and A Claudio Cuello, and Gassan Massarweh, and Serge Gauthier, and Pedro Rosa-Neto, and
January 2020, Alzheimer's & dementia (Amsterdam, Netherlands),
Min Su Kang, and Arturo Aliaga Aliaga, and Monica Shin, and Sulantha Mathotaarachchi, and Andrea L Benedet, and Tharick A Pascoal, and Joseph Therriault, and Mira Chamoun, and Melissa Savard, and Gabriel A Devenyi, and Axel Mathieu, and M Mallar Chakravarty, and Åsa Sandelius, and Kaj Blennow, and Henrik Zetterberg, and Jean-Paul Soucy, and A Claudio Cuello, and Gassan Massarweh, and Serge Gauthier, and Pedro Rosa-Neto, and
May 2017, Neuroscience letters,
Min Su Kang, and Arturo Aliaga Aliaga, and Monica Shin, and Sulantha Mathotaarachchi, and Andrea L Benedet, and Tharick A Pascoal, and Joseph Therriault, and Mira Chamoun, and Melissa Savard, and Gabriel A Devenyi, and Axel Mathieu, and M Mallar Chakravarty, and Åsa Sandelius, and Kaj Blennow, and Henrik Zetterberg, and Jean-Paul Soucy, and A Claudio Cuello, and Gassan Massarweh, and Serge Gauthier, and Pedro Rosa-Neto, and
January 2023, PloS one,
Min Su Kang, and Arturo Aliaga Aliaga, and Monica Shin, and Sulantha Mathotaarachchi, and Andrea L Benedet, and Tharick A Pascoal, and Joseph Therriault, and Mira Chamoun, and Melissa Savard, and Gabriel A Devenyi, and Axel Mathieu, and M Mallar Chakravarty, and Åsa Sandelius, and Kaj Blennow, and Henrik Zetterberg, and Jean-Paul Soucy, and A Claudio Cuello, and Gassan Massarweh, and Serge Gauthier, and Pedro Rosa-Neto, and
June 2022, Pediatric research,
Min Su Kang, and Arturo Aliaga Aliaga, and Monica Shin, and Sulantha Mathotaarachchi, and Andrea L Benedet, and Tharick A Pascoal, and Joseph Therriault, and Mira Chamoun, and Melissa Savard, and Gabriel A Devenyi, and Axel Mathieu, and M Mallar Chakravarty, and Åsa Sandelius, and Kaj Blennow, and Henrik Zetterberg, and Jean-Paul Soucy, and A Claudio Cuello, and Gassan Massarweh, and Serge Gauthier, and Pedro Rosa-Neto, and
August 2020, Clinical neurology and neurosurgery,
Min Su Kang, and Arturo Aliaga Aliaga, and Monica Shin, and Sulantha Mathotaarachchi, and Andrea L Benedet, and Tharick A Pascoal, and Joseph Therriault, and Mira Chamoun, and Melissa Savard, and Gabriel A Devenyi, and Axel Mathieu, and M Mallar Chakravarty, and Åsa Sandelius, and Kaj Blennow, and Henrik Zetterberg, and Jean-Paul Soucy, and A Claudio Cuello, and Gassan Massarweh, and Serge Gauthier, and Pedro Rosa-Neto, and
October 2019, Journal of neuroinflammation,
Min Su Kang, and Arturo Aliaga Aliaga, and Monica Shin, and Sulantha Mathotaarachchi, and Andrea L Benedet, and Tharick A Pascoal, and Joseph Therriault, and Mira Chamoun, and Melissa Savard, and Gabriel A Devenyi, and Axel Mathieu, and M Mallar Chakravarty, and Åsa Sandelius, and Kaj Blennow, and Henrik Zetterberg, and Jean-Paul Soucy, and A Claudio Cuello, and Gassan Massarweh, and Serge Gauthier, and Pedro Rosa-Neto, and
February 2022, Movement disorders : official journal of the Movement Disorder Society,
Min Su Kang, and Arturo Aliaga Aliaga, and Monica Shin, and Sulantha Mathotaarachchi, and Andrea L Benedet, and Tharick A Pascoal, and Joseph Therriault, and Mira Chamoun, and Melissa Savard, and Gabriel A Devenyi, and Axel Mathieu, and M Mallar Chakravarty, and Åsa Sandelius, and Kaj Blennow, and Henrik Zetterberg, and Jean-Paul Soucy, and A Claudio Cuello, and Gassan Massarweh, and Serge Gauthier, and Pedro Rosa-Neto, and
July 1999, Biochemistry. Biokhimiia,
Copied contents to your clipboard!